Table 1

Monte Carlo bias and variance for the WIPL estimates under different scenarios. The first 4 scenarios belong to Design A and have an average of 1778 (94) placebo (vaccine) cases. Scenario 5 belongs to Design B and has an average of 242 (27) placebo (vaccine) cases. Scenarios 6-8 belong to Design C and has 1254, 94, 25 on placebo original, vaccine, and CPV vaccine arms. All scenarios include β1,β2,β3 in cox model and do not use X(T) value from cases in model fitting unless otherwise noted.

DesignScenarioFeatureDataβ0β1β2β3
A.1) β1,β2,β3 togetherBiasVaccine5e–4–1e–5–0.031
ReferenceAll–0.0021.3e–4–9e–5–0.037
VarianceVaccine0.1610.3311.707
All1.8250.1580.3260.453
2) No β3BiasVaccine0.009–0.009
All–0.0050.014–0.014
VarianceVaccine0.1280.281
All1.8300.0410.190
3) No β2 and β3BiasVaccine0.002
All–0.0340.009
VarianceVaccine0.063
All0.2460.030
4) Add X(T)BiasVaccine–0.0050.007–0.032
All–0.007–0.0030.005–0.036
VarianceVaccine0.1290.3021.682
All1.7740.1250.2900.396
B.5) β1,β2,β3 togetherBiasVaccine–0.0200.012–0.108
Few EventsAll–0.014–0.0220.015–0.111
VarianceVaccine0.4791.0816.523
All6.5100.4581.0551.518
C.6) β1,β2,β3 togetherBiasVaccine–0.0020.002–0.013
Placebo VxAll–0.009–0.0020.003–0.023
VarianceVaccine0.1570.2960.461
All1.4340.1570.2960.430
7) No β3BiasVaccine0.001–0.0003
All–0.0120.005–0.003
VarianceVaccine0.0420.161
All1.4230.0360.152
8) No β2 and β3BiasVaccine0.0002
All–0.0120.002
VarianceVaccine0.029
All0.2400.025
DesignScenarioFeatureDataβ0β1β2β3
A.1) β1,β2,β3 togetherBiasVaccine5e–4–1e–5–0.031
ReferenceAll–0.0021.3e–4–9e–5–0.037
VarianceVaccine0.1610.3311.707
All1.8250.1580.3260.453
2) No β3BiasVaccine0.009–0.009
All–0.0050.014–0.014
VarianceVaccine0.1280.281
All1.8300.0410.190
3) No β2 and β3BiasVaccine0.002
All–0.0340.009
VarianceVaccine0.063
All0.2460.030
4) Add X(T)BiasVaccine–0.0050.007–0.032
All–0.007–0.0030.005–0.036
VarianceVaccine0.1290.3021.682
All1.7740.1250.2900.396
B.5) β1,β2,β3 togetherBiasVaccine–0.0200.012–0.108
Few EventsAll–0.014–0.0220.015–0.111
VarianceVaccine0.4791.0816.523
All6.5100.4581.0551.518
C.6) β1,β2,β3 togetherBiasVaccine–0.0020.002–0.013
Placebo VxAll–0.009–0.0020.003–0.023
VarianceVaccine0.1570.2960.461
All1.4340.1570.2960.430
7) No β3BiasVaccine0.001–0.0003
All–0.0120.005–0.003
VarianceVaccine0.0420.161
All1.4230.0360.152
8) No β2 and β3BiasVaccine0.0002
All–0.0120.002
VarianceVaccine0.029
All0.2400.025
Table 1

Monte Carlo bias and variance for the WIPL estimates under different scenarios. The first 4 scenarios belong to Design A and have an average of 1778 (94) placebo (vaccine) cases. Scenario 5 belongs to Design B and has an average of 242 (27) placebo (vaccine) cases. Scenarios 6-8 belong to Design C and has 1254, 94, 25 on placebo original, vaccine, and CPV vaccine arms. All scenarios include β1,β2,β3 in cox model and do not use X(T) value from cases in model fitting unless otherwise noted.

DesignScenarioFeatureDataβ0β1β2β3
A.1) β1,β2,β3 togetherBiasVaccine5e–4–1e–5–0.031
ReferenceAll–0.0021.3e–4–9e–5–0.037
VarianceVaccine0.1610.3311.707
All1.8250.1580.3260.453
2) No β3BiasVaccine0.009–0.009
All–0.0050.014–0.014
VarianceVaccine0.1280.281
All1.8300.0410.190
3) No β2 and β3BiasVaccine0.002
All–0.0340.009
VarianceVaccine0.063
All0.2460.030
4) Add X(T)BiasVaccine–0.0050.007–0.032
All–0.007–0.0030.005–0.036
VarianceVaccine0.1290.3021.682
All1.7740.1250.2900.396
B.5) β1,β2,β3 togetherBiasVaccine–0.0200.012–0.108
Few EventsAll–0.014–0.0220.015–0.111
VarianceVaccine0.4791.0816.523
All6.5100.4581.0551.518
C.6) β1,β2,β3 togetherBiasVaccine–0.0020.002–0.013
Placebo VxAll–0.009–0.0020.003–0.023
VarianceVaccine0.1570.2960.461
All1.4340.1570.2960.430
7) No β3BiasVaccine0.001–0.0003
All–0.0120.005–0.003
VarianceVaccine0.0420.161
All1.4230.0360.152
8) No β2 and β3BiasVaccine0.0002
All–0.0120.002
VarianceVaccine0.029
All0.2400.025
DesignScenarioFeatureDataβ0β1β2β3
A.1) β1,β2,β3 togetherBiasVaccine5e–4–1e–5–0.031
ReferenceAll–0.0021.3e–4–9e–5–0.037
VarianceVaccine0.1610.3311.707
All1.8250.1580.3260.453
2) No β3BiasVaccine0.009–0.009
All–0.0050.014–0.014
VarianceVaccine0.1280.281
All1.8300.0410.190
3) No β2 and β3BiasVaccine0.002
All–0.0340.009
VarianceVaccine0.063
All0.2460.030
4) Add X(T)BiasVaccine–0.0050.007–0.032
All–0.007–0.0030.005–0.036
VarianceVaccine0.1290.3021.682
All1.7740.1250.2900.396
B.5) β1,β2,β3 togetherBiasVaccine–0.0200.012–0.108
Few EventsAll–0.014–0.0220.015–0.111
VarianceVaccine0.4791.0816.523
All6.5100.4581.0551.518
C.6) β1,β2,β3 togetherBiasVaccine–0.0020.002–0.013
Placebo VxAll–0.009–0.0020.003–0.023
VarianceVaccine0.1570.2960.461
All1.4340.1570.2960.430
7) No β3BiasVaccine0.001–0.0003
All–0.0120.005–0.003
VarianceVaccine0.0420.161
All1.4230.0360.152
8) No β2 and β3BiasVaccine0.0002
All–0.0120.002
VarianceVaccine0.029
All0.2400.025
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close